Lung Therapeutics competitors

Lung Therapeutics Competitors include RespireRx Pharmaceuticals, Anacor Pharmaceuticals, IntelGenx and Mylan.
Add company...
Lung Therapeutics
Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions.
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
Anacor Pharmaceuticals
Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.
IntelGenx
IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
Mylan
Mylan offers generic and specialty pharmaceutical products.
Founding Date
Founding Date
2013
Founding Date
1988
Founding Date
2002
Founding Date
2003
Founding Date
1961
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Glen Rock, US HQ
Locations
Palo Alto, US HQ
Locations
Saint-Laurent, CA HQ
Locations
Canonsburg, US HQ
Hertfordshire, GB
Employees
Employees
1121% decrease
Employees
1
Employees
N/A
Employees
12
Employees
35,000
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.3 m
Valuation ($)
N/A
Valuation ($)
50.1 m
Valuation ($)
16.8 b
Facebook likes
Facebook likes
265
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
2.1 k
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1 k
Twitter followers
7.2 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$82.4m (FY, 2015)
Revenue (est.)
$5.2m (FY, 2016)
Revenue (est.)
$7.6b (FY, 2014)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$4m (FY, 2015)
Cost of goods
N/A
Cost of goods
$4.2b (FY, 2014)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$78.3m (FY, 2015)
Gross profit
N/A
Gross profit
$3.5b (FY, 2014)
Net income
Net income
N/A
Net income
($4.3m) (FY, 2017)
Net income
($61.2m) (FY, 2015)
Net income
($1.2m) (FY, 2016)
Net income
$933.1m (FY, 2014)

Funding

Total funding raised
Total funding raised
$ 17.9m
Total funding raised
N/A
Total funding raised
$ 198.4m
Total funding raised
$ 1.7m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

RespireRx Pharmaceuticals
HQ
Glen Rock, US
Employees
1

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

View company
Anacor Pharmaceuticals
HQ
Palo Alto, US

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.

View company
IntelGenx
HQ
Saint-Laurent, CA
Employees
12

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.

View company
Mylan
HQ
Canonsburg, US
Employees
35,000

Mylan offers generic and specialty pharmaceutical products.

View company